Fingerprint
Dive into the research topics of 'A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically